Pre_GI: SWBIT SVG BLASTN

Query: NC_004459:349500 Vibrio vulnificus CMCP6 chromosome I, complete sequence

Lineage: Vibrio vulnificus; Vibrio; Vibrionaceae; Vibrionales; Proteobacteria; Bacteria

General Information: Pathogen in immunocompromised patients. This genus is abundant in marine or freshwater environments such as estuaries, brackish ponds, or coastal areas; regions that provide an important reservoir for the organism in between outbreaks of the disease. Vibrio can affect shellfish, finfish, and other marine animals and a number of species are pathogenic for humans. Organisms of this species are opportunistic pathogens that can attack immunocompromised patients and causes gastroenteritis (inflammation of mucous membranes of stomach and intestine), wound infections, and primary septicemia (spread of the organism through the blood). This organism is the major cause of death from eating raw oysters, especially in people with liver damage. It only affects humans and other primates.

- Sequence; - BLASTN hit (Low score = Light, High score = Dark)
- hypothetical protein; - cds: hover for description

BLASTN Alignment.txt

Subject: NC_013508:2870954 Edwardsiella tarda EIB202, complete genome

Lineage: Edwardsiella tarda; Edwardsiella; Enterobacteriaceae; Enterobacteriales; Proteobacteria; Bacteria

General Information: Edwardsiella tarda is a Gram-negative member of the normal gut microflora of fish, humans, chickens and other animals. This organism is also a serious pathogen of marine and freshwater fish and has been isolated from channel catfish, Japanese eels, flounder, tilapia, and other economically important fish. Infection by this organism is characterized by septicemia, internal abscesses, and skin lesions. This disease is often associated with poor water quality and mortality in aquaculture can be high. Edwardsiella tarda also causes opportunistic infections in humans, most commonly gastroenteritis and wound infections. However, this organism has been isolated from cases of septicemia and meningitis, primarily in immunocompromised patients.